Repligen Q3 Adj. EPS $0.46 Beats $0.42 Estimate, Sales $188.805M Beat $181.338M Estimate

Repligen (NASDAQ: RGEN) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.42 by 10.05 percent. This is a 6.98 percent increase over earnings of $0.43 per share from the same period last year. The company reported quarterly sales of $188.805 million which beat the analyst consensus estimate of $181.338 million by 4.12 percent. This is a 21.91 percent increase over sales of $154.871 million the same period last year.